Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Palliative Performance Scale (PPS), ECOG and Albumin Levels Can Predict Prognosis in Patients with Hematological Malignancies Followed at a Palliative Care Service

Lucas W. Weiss Santos, Viviane Catini Nishiyama, Fabiana Gomes de Oliveira Miranda Manoel, Mariana Munari Magnus, Fernando Ferreira Costa, Paula de Melo Campos

Blood (2024) 144 (Supplement 1): 7587.

https://doi.org/10.1182/blood-2024-209095

Published: 2024

Journal Articles

Podoplanin Expression Measured By Flow Cytometry Accurately Identifies Patients with Acute Promyelocytic Leukemia at Diagnosis

Camilla Maria de Alencar Saraiva, Carla Roberta Peachazepi Moraes, Bruno Kosa Lino Duarte, Paula de Melo Campos, Gislaine Borba Oliveira, Sara Teresinha Olalla Saad, Erich Vinicius De Paula

Blood (2023) 142 (Supplement 1): 6009.

https://doi.org/10.1182/blood-2023-188321

Published: 2023

Journal Articles

Cognitive Assessment in Brazilian Adults with Sickle Cell Disease (SCD): The Burdens of Sociocultural Background and Correlations with Neuroimaging Findings

Pedro Junqueira Fleury Silva, Caroline Martins Silva, Brunno Machado de Campos, Paula De Melo Campos, Samuel de Souza Medina, Andreza Lamonica, Fernando Cendes, Fernando Ferreira Costa, Sara T Olalla Saad, Bruno Deltreggia Benites

Blood (2022) 140 (Supplement 1): 2576–2577.

https://doi.org/10.1182/blood-2022-166596

Published: 2022

Journal Articles

The Association of Heterozygous β-Thalassemia and β-Spectrin Mutations May Result in a Phenotype of Severe Anemia

Guilherme Antonio de Paula Machado, Isabella Macedo Toni, Dulcinéia Martins Albuquerque, Kleber Yotsumoto Fertrin, Fernando Ferreira Costa, Paula De Melo Campos

Blood (2022) 140 (Supplement 1): 11068–11069.

https://doi.org/10.1182/blood-2022-167957

Published: 2022

Journal Articles

Myelodysplastic Syndromes: Have You Seen Your Patient Beyond His Hemoglobin?

Raíssa Pires Camargo Ebert, Mariana Munari Magnus, Cristina Bueno Terzi, Antonio Luis Eiras Falcão, Fernando Ferreira Costa, Sara T Olalla Saad, Paula De Melo Campos

Blood (2021) 138 (Supplement 1): 4660.

https://doi.org/10.1182/blood-2021-153569

Published: 2021

Journal Articles

Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients

Paula De Melo Campos, Katia B Pagnano, Rubia Isler Mancuso, Fernanda Isabel Della Via, Ângela Condotta Tinoco, Guilherme Rossi Assis-Mendonça, Leandro Luiz Lopes Freitas, Fabiola Traina, Sara T Olalla Saad

Blood (2021) 138 (Supplement 1): 2584.

https://doi.org/10.1182/blood-2021-151077

Published: 2021

Journal Articles

Crizanlizumab Therapy Is Associated with Lower Levels of Circulating Extracellular Vesicles in Sickle Cell Disease Patients

Cristiane Maria de Souza, Carolina Lanaro, Irene Pereira dos Santos, Oladele Olatunya, Sara T Olalla Saad, Bruno Deltreggia Benites, Paula De Melo Campos, Kleber Yotsumoto Fertrin, Fernando Ferreira Costa

Blood (2021) 138 (Supplement 1): 955.

https://doi.org/10.1182/blood-2021-153377

Published: 2021

Journal Articles

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Caroline Martins Silva, Samuel Souza Medina, MD MSc, Paula De Melo Campos, MD PhD, Fernando Ferreira Costa, MD PhD, Sara T Olalla Saad, MD PhD, Bruno Deltreggia Benites, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138486

Published: 2020

Journal Articles

Co-occurrence of DNMT3A , NPM1 , FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis

Blood (2020) 135 (11): 870–875.

https://doi.org/10.1182/blood.2019003339

Published: 2020

Includes: Supplemental data

Journal Articles

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Paula De Melo Campos, MD, Katia B Pagnano, MD PhD, Rubia Mancuso, Francisco Breno S. Teófilo, Juan L Coelho-Silva, BSc, MSc, Fernanda I Della Via, MSc, Leandro Luiz Lopes Freitas, MD PhD, Hernandes F. Carvalho, PhD, Fernando Ferreira Costa, MD PhD, Fabiola Traina, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 554.

https://doi.org/10.1182/blood-2019-130648

Published: 2019

Journal Articles

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Maria Carolina Costa Melo Svidnicki, PhD, Paula De Melo Campos, MD, Moisés Alves Ferreira Filho, PhD, Caio Augusto Leme Fujiura, Tetsuichi Yoshizato, MD PhD, Hideki Makishima, MD PhD, Seishi Ogawa, MD PhD, Sara T Olalla Saad, PhD

Blood (2019) 134 (Supplement_1): 5395.

https://doi.org/10.1182/blood-2019-128764

Published: 2019

Journal Articles

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

Pedro de Oliveira Toro da Silva, Cristina Bueno Terzi, MD PhD, Antonio Luis Eiras Falcão, MD PhD, Sara T Olalla Saad, PhD, Fernando Ferreira Costa, MD PhD, Paula De Melo Campos, MD

Blood (2019) 134 (Supplement_1): 4681.

https://doi.org/10.1182/blood-2019-128884

Published: 2019

Journal Articles

The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms

Bruna Alves Fenerich, BSc, João Agostinho Machado-Neto, BSc, Ana Paula Nunes Rodrigues Alves, MSc, Paula De Melo Campos, MD PhD, Jaqueline Cristina Fernandes, BSc, MSc, Juan Luiz Coelho-Silva, BSc, MSc, Renata Scopim Ribeiro, BSc, MSc, Fernanda B da Silva, BSc and MSc, Priscila Santos Scheucher, PhD, Lorena Lobo Figueiredo-Pontes, MD PhD, Eduardo Magalhães Rego, MDPhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 1253.

https://doi.org/10.1182/blood.V130.Suppl_1.1253.1253

Published: 2017

Journal Articles

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

Renata Scopim Ribeiro, BSc, MSc, João Agostinho Machado-Neto, BSc, Paula De Melo Campos, MD PhD, Christopher A. Eide, Samantha L Savage, Irene Lorand-Metze, MD PhD, Cristina E. Tognon, PhD, Fernando Ferreira Costa, MD PhD, Brian J. Druker, MD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 3969.

https://doi.org/10.1182/blood.V130.Suppl_1.3969.3969

Published: 2017

Journal Articles

Pharmacological IRS1/2 Inhibition Induces Apoptosis in BCR-ABL1 T315I mutant Cells

Renata Scopim-Ribeiro, M.Sc., João Agostinho Machado-Neto, PhD, Christopher A. Eide, Paula de Melo Campos, PhD, Priscila Santos Scheucher, PhD, Sara Teresinha Olalla Saad, MD PhD, Eduardo Magalhães Rego, MD, PhD, Cristina E. Tognon, Brian J. Druker, MD, Fabiola Traina, MD, PhD

Blood (2016) 128 (22): 1886.

https://doi.org/10.1182/blood.V128.22.1886.1886

Published: 2016

Journal Articles

A Novel Antisense Long Noncoding RNA Modulates NR4A1 Protein Level in Myeloid Malignancies

Flávia Adolfo Corrocher, MSc, Ada Congrains, PhD, Fernanda Soares Niemann, MSc, Bruna Palodetto, MSc, Fernanda Marconi Roversi, PhD, Mariana Ozello Baratti, PhD, Paula de Melo Campos, PhD, Sara Teresinha Olalla Saad, PhD MD

Blood (2015) 126 (23): 2442.

https://doi.org/10.1182/blood.V126.23.2442.2442

Published: 2015

Journal Articles

Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells

Renata Scopim-Ribeiro, M.Sc., João Agostinho Machado-Neto, PhD, Paula de Melo Campos, PhD, Adriana da Silva Santos Duarte, PhD, Priscila Santos Scheucher, PhD, Amélia Góes, PhD, Sara Teresinha Olalla Saad, MD, PhD, Belinda Pinto Simoes, MD, PhD, Eduardo Magalhães Rego, MD, PhD, Fabiola Traina, MD, PhD

Blood (2015) 126 (23): 2772.

https://doi.org/10.1182/blood.V126.23.2772.2772

Published: 2015

Journal Articles

IRS2 Inhibition Reduces Cell Proliferation and Has Cumulative Effects with Ruxolitinib in JAK2 V617F Cells

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Patricia Favaro, PhD, Fernando Ferreira Costa, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3219.

https://doi.org/10.1182/blood.V124.21.3219.3219

Published: 2014

Journal Articles

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Adriana Silva Santos Duarte, PhD, Irene Lorand-Metze, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3229.

https://doi.org/10.1182/blood.V124.21.3229.3229

Published: 2014

Journal Articles

Nix (BNIP3L) Is Downregulated in High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia and Its Silencing Enhances Decitabine-Mediated Apoptosis

Mariana Lazarini, PhD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Fernando V Pericole, MD, Karla Priscila Ferro, PhD, Paula de Melo Campos, MD, Fabiola Traina, MD PhD, Sara T.O. Saad, MD, PhD

Blood (2014) 124 (21): 3239.

https://doi.org/10.1182/blood.V124.21.3239.3239

Published: 2014

NARROW

Palliative Performance Scale (PPS), ECOG and Albumin Levels Can Predict Prognosis in Patients with Hematological Malignancies Followed at a Palliative Care Service

Podoplanin Expression Measured By Flow Cytometry Accurately Identifies Patients with Acute Promyelocytic Leukemia at Diagnosis

Cognitive Assessment in Brazilian Adults with Sickle Cell Disease (SCD): The Burdens of Sociocultural Background and Correlations with Neuroimaging Findings

The Association of Heterozygous β-Thalassemia and β-Spectrin Mutations May Result in a Phenotype of Severe Anemia

Myelodysplastic Syndromes: Have You Seen Your Patient Beyond His Hemoglobin?

Final Results of the Fibromet Trial: An Open Label Phase II Study to Evaluate Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients

Crizanlizumab Therapy Is Associated with Lower Levels of Circulating Extracellular Vesicles in Sickle Cell Disease Patients

Platelet Counts and Mean Platelet Volume As Markers of Clinical Severity in Sickle Cell Disease

Co-occurrence of DNMT3A , NPM1 , FLT3 mutations identifies a subset of acute myeloid leukemia with adverse prognosis

Analysis of Metformin Effects on Bone Marrow Fibrosis and Disease Progression in Primary Myelofibrosis Patients: Preliminary Results of an Open Label Phase II Trial (FIBROMET)

Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms

Analysis of the Eligibility of Patients with Sickle Cell Disease for Palliative Care

The Pharmacological IGF1R-IRS1/2 Inhibitor NT157 Presents Multiple Anti-Neoplastic Effects in Myeloproliferative Neoplasms

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

Pharmacological IRS1/2 Inhibition Induces Apoptosis in BCR-ABL1 T315I mutant Cells

A Novel Antisense Long Noncoding RNA Modulates NR4A1 Protein Level in Myeloid Malignancies

Pharmacological IRS1/2 Inhibition Reduces Cell Viability in BCR-ABL1 Positive Cells

IRS2 Inhibition Reduces Cell Proliferation and Has Cumulative Effects with Ruxolitinib in JAK2 V617F Cells

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

Nix (BNIP3L) Is Downregulated in High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia and Its Silencing Enhances Decitabine-Mediated Apoptosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only